AYA.AX ASX
Artrya Limited
1W: -2.9%
1M: -11.5%
3M: -38.1%
YTD: +6.3%
1Y: +78.7%
3Y: +1270.4%
A$3.46 ($2.41)
-0.24 (-6.49%)
Weekly Expected Move ±14.0%
A$3
A$3
A$4
A$4
A$5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market CapA$603.0M ($419.2M)
52W Range2.36-6.49
Volume3,425,791
Avg Volume1,029,054
Beta0.59
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJohn Konstantopoulos
Employees43
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2021-11-25
Websiteartrya.com
1257 Hay Street
West Perth, WA 6005
AU
West Perth, WA 6005
AU
61 8 6478 7816
About Artrya Limited
Artrya Limited is a medical technology firm that harnesses artificial intelligence (AI) to pinpoint individuals at risk of developing coronary artery disease. The company's key offering is Salix, a cloud-based software application. Salix leverages Artrya's proprietary AI to automate the identification of coronary artery disease through the analysis of coronary computed tomography angiography (CCTA) scans. Founded in 2018, the company is headquartered in West Perth, Australia.
Latest News
No recent news
Recent Insider Trades
No insider trades found